Roche Holding Ltd RHHBY Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board

Sep 7, 2013 at 2:27 PM

Roche Holding Ltd RHHBY Company Overview

Stock Message Board http://investorshangout.com/search?q=RHHBY&am...mp;yt1=Go!

Roche Holding Ltd RHHBY Current Price and Quotes
Last Price 62.64
Previous Close 61.98 Open 62.24
Daily Range 62.80 - 61.96 52wk Range 66.52 - 45.89
Volume 800,862 Dividend 1.6945
Average Vol (3m) 595,820 Yield 2.7
Roche Holding Ltd RHHBY

Company Verified Profile
Company Information

Grenzacherstrasse 124
Basel 4070
Switzerland

Website: http://www.roche.com
Phone: +41 61 688 1111
Email: rocheirna@gene.com
Find us on:

Roche Holding Ltd RHHBY
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing m...

Roche Holding Ltd RHHBY
Financial Reportings and Disclosures

Reporting Status International Reporting: SIX Swiss Exchange
Audited Financials Audited
Latest Report Jun 30, 2013 Semi-Annual Report
CIK 0000896566
Fiscal Year End 12/31
OTC Marketplace OTCQX International Premier
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Switzerland
Year of Inc. 1896
Employees 82089 a/o Dec 31, 2012
Company Officers/Contacts

Severin Schwan CEO
Karl Rieder CFO
Alan Hippe CFO
Thomas Kudsk Larsen Head of IR
Company Directors

Franz B. Humer Chairman
Service Providers

DAD/PAL
J.P. Morgan
4 New York Plaza
14th Floor
New York, NY, 10004
United States

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Roche Holding Ltd RHHBY
RHHBY Security Details Other Company Securities

Share Structure

Market Value1 $176,056,660,512 a/o Sep 06, 2013
Shares Outstanding 702,652,700 a/o Jun 30, 2013
Float 688,468,810 a/o Dec 31, 2012
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (1.69455) Mar 07, 2013 Mar 11, 2013
Dividend (1.55643) Mar 08, 2012 Mar 12, 2012
Dividend (1.12965) Mar 03, 2011 Mar 07, 2011 Apr 25, 2011
Security Notes

Ratio Change=1 ADR to 0.25 Ord from 1 ADR to 0.5 Ord. Basis: 2 for 1 forward split. Rec date=1-05-09. Pay date=1-08-09.
Ratio Change=1 ADR to 0.5 Ord from 1 ADR to 1 Ord. Basis: 2 for 1 forward split. Rec date=1-21-05. Pay date=1-24-05
Capital Change=shs increased by 2 for 1 split Ex-date=01/25/2005. Rec date=01/21/2005. Pay date=01/24/2005.
Capital Change=shs increased by 2 for 1 split. Ex-date=01/09/2009. Rec date=01/05/2009. Pay date=01/08/2009.
Non US Stock Exchange Listing

ROG - SIX Swiss Exchange - Qualified
Short Selling Data

Short Interest 79,776 (-55.2%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)

JPMorgan Depositary Receipts

Roche Holding Ltd RHHBY Recent News

Sept 4, 2013 Ventana and EMC join forces to take digital pathology into the world of Big Data
Aug 27, 2013 OTC Daily Alert Stock Watch - ROCHE HOLDING LTD. (OTC: RHHBY)
Aug 19, 2013 Research and Markets: Global Stem Cell Anticancer Therapeutics Market 2012-2016 with Roche Holding AG, Teva Pharmaceutical Industries Ltd and Verastem Inc. Dominating
Jul 30, 2013 Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo
Jul 24, 2013 Genentech's Obinutuzumab (GA101) Delayed Disease Progression Longer Than Rituxan(R) in People with One of the Most Common Forms of Blood Cancer
Jul 8, 2013 Roche submits filing to FDA for cervical cancer primary screening indication for cobas® HPV Test
Jul 3, 2013 FDA Grants Genentech's Obinutuzumab (GA101) Priority Review for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Jul 2, 2013 FDA Grants Genentech's Perjeta Regimen Priority Review for Use Before Surgery in HER2-Positive Early Stage Breast Cancer
Jul 1, 2013 Roche Diagnostics ranked #1 in overall service performance in independent survey of U.S. clinical laboratories
Jun 26, 2013 FDA approves new streamlined workflow option for Roche's cobas HPV Test

Roche Holding Ltd RHHBY Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue 51,832,000 47,175,000
Cost of Revenue 13,301,000 12,771,000
Gross Profit 38,531,000 34,404,000
Operating Expenses

Research and Development 10,435,000 8,904,000
Sales, General and Admin. 12,664,000 11,112,000
Non-Recurring Items - -
Other - -
Operating Income 15,431,000 14,388,000
Income From Continuing Operations

Add'l Income/Expense Items 515,000 692,000
Earnings Before Interest and Tax 15,946,000 15,093,000
Interest Expense 2,483,000 2,383,000
Earnings Before Tax 13,463,000 12,710,000
Income Tax 2,786,000 2,503,000
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - 13,000
Net Income Cont. Operations 10,677,000 10,219,000
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 10,677,000 10,206,000
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 10,677,000 10,206,000

RHHBY Roche Holding Ltd Research DD Guide

RHHBY Roche Holding Ltd Stock Message Board http://investorshangout.com/search?q=RHHBY&am...mp;yt0=Go!
RHHBY Roche Holding Ltd Stock Quote http://www.otcmarkets.com/stock/RHHBY/quote
RHHBY Roche Holding Ltd Stock Chart http://www.otcmarkets.com/stock/RHHBY/chart
RHHBY Roche Holding Ltd Company Info http://www.otcmarkets.com/stock/RHHBY/company-info
RHHBY Roche Holding Ltd Recent News http://www.otcmarkets.com/stock/RHHBY/news
RHHBY Roche Holding Ltd Financials http://www.otcmarkets.com/stock/RHHBY/financials
RHHBY Roche Holding Ltd Filings and Disclosure http://www.otcmarkets.com/stock/RHHBY/filings
RHHBY Roche Holding Ltd Short Sales http://www.otcmarkets.com/stock/RHHBY/short-sales
RHHBY Roche Holding Ltd Insider Disclosure http://www.otcmarkets.com/stock/RHHBY/insider-transactions
RHHBY Roche Holding Ltd Research Reports http://www.otcmarkets.com/stock/RHHBY/research
RHHBY Roche Holding Ltd Summary http://finance.yahoo.com/q?s=RHHBY
RHHBY Roche Holding Ltd Historical Prices http://finance.yahoo.com/q/hp?s=RHHBY+Historical+Prices
RHHBY Roche Holding Ltd Interactive Chart http://finance.yahoo.com/echarts?s=RHHBY
RHHBY Roche Holding Ltd Basic Chart http://finance.yahoo.com/q/bc?s=RHHBY+Basic+Chart
RHHBY Roche Holding Ltd Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=RHHBY+Basic+Tech.+Analysis
RHHBY Roche Holding Ltd Headlines http://finance.yahoo.com/q/h?s=RHHBY+Headlines
RHHBY Roche Holding Ltd Press Releases http://finance.yahoo.com/q/p?s=RHHBY+Press+Releases
RHHBY Roche Holding Ltd Company Profile http://finance.yahoo.com/q/pr?s=RHHBY+Profile
RHHBY Roche Holding Ltd Key Statistics http://finance.yahoo.com/q/ks?s=RHHBY+Key+Statistics
RHHBY Roche Holding Ltd Industry http://finance.yahoo.com/q/in?s=RHHBY+Industry
RHHBY Roche Holding Ltd Major Holders http://finance.yahoo.com/q/mh?s=RHHBY+Major+Holders
RHHBY Roche Holding Ltd Insider Transactions http://finance.yahoo.com/q/it?s=RHHBY+Insider+Transactions
RHHBY Roche Holding Ltd Insider Roster http://finance.yahoo.com/q/ir?s=RHHBY+Insider+Roster
RHHBY Roche Holding Ltd Income Statement http://finance.yahoo.com/q/is?s=RHHBY
RHHBY Roche Holding Ltd Balance Sheet http://finance.yahoo.com/q/bs?s=RHHBY
RHHBY Roche Holding Ltd Cash Flow http://finance.yahoo.com/q/cf?s=RHHBY+Cash+Flow&annual
RHHBY Roche Holding Ltd Nasdaq http://www.nasdaq.com/symbol/RHHBY
RHHBY Roche Holding Ltd Market Watch http://www.marketwatch.com/investing/stock/RHHBY
RHHBY Roche Holding Ltd Bloomberg http://www.bloomberg.com/quote/RHHBY:US
RHHBY Roche Holding Ltd Morningstar http://quotes.morningstar.com/stock/s?t=RHHBY
RHHBY Roche Holding Ltd Bussinessweek http://investing.businessweek.com/research/st...cker=RHHBY
RHHBY Roche Holding Ltd Barchart http://www.barchart.com/quotes/stocks/RHHBY
RHHBY Roche Holding Ltd OTC Short Report http://otcshortreport.com/index.php?index=RHHBY
RHHBY Roche Holding Ltd Investopedia http://www.investopedia.com/markets/stocks/RHHBY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...